|
No. of available beds (No. of surveyed wards)
|
1135 (35)
|
1345 (40)
|
1359 (44)
|
1375 (46)
|
1357 (50)
|
–
|
|
No. of patients admitted
|
1018
|
1150
|
1173
|
1214
|
1182
|
NA
|
|
No. of patients on antimicrobials
|
558 (55%)
|
519 (45%)
|
592 (50%)
|
589 (49%)
|
558 (47%)
|
0.02
|
|
No. of patients on antibacterials for systemic use (J01)
|
550 (54%)
|
504 (44%)
|
562 (48%)
|
550 (45%)
|
501 (42%)
|
< 0.01
|
|
Age, median years (range)
|
73 (16–99)
|
69 (17–100)
|
71 (17–100)
|
72 (15–99)
|
71 (16–101)
|
–
|
|
Male
|
290 (53%)
|
281 (54%)
|
340 (57%)
|
345 (59%)
|
330 (59%)
|
–
|
|
Medical patients
|
704 (69%)
|
802 (70%)
|
849 (72%)
|
914 (75%)
|
912 (77%)
|
< 0.01
|
|
Surgical patients
|
278 (27%)
|
297 (26%)
|
290 (25%)
|
273 (22%)
|
226 (19%)
|
< 0.01
|
|
Intensive care patients
|
36 (4%)
|
51 (4%)
|
34 (3%)
|
27 (2%)
|
44 (4%)
|
0.27
|
|
No. of antimicrobials
|
768
|
755
|
839
|
821
|
780
|
–
|
|
Antibacterials for systemic use (J01)
|
727 (95%)
|
647 (86%)
|
692 (82%)
|
665 (81%)
|
615 (79%)
|
–
|
|
Antimalarials (P01BA)
|
0
|
2 (0.2%)
|
0
|
10 (1%)
|
4 (0.5%)
|
–
|
|
Antimycobacterials (J04)
|
21 (3%)
|
51 (7%)
|
50 (6%)
|
44 (5%)
|
52 (7%)
|
–
|
|
Antimycotics for systemic use (J02)
|
11 (1%)
|
19 (3%)
|
13 (2%)
|
18 (2%)
|
20 (3%)
|
–
|
|
Antivirals for systemic use (J05)
|
8 (1%)
|
26 (3%)
|
80 (10%)*
|
70 (9%)
|
83 (11%)
|
–
|
|
Intestinal anti-infectives (A07A)
|
1 (< 1%)
|
10 (1%)
|
4 (< 1%)
|
14 (2%)
|
6 (< 1%)
|
–
|
